Dixon Hubard Feinour & Brown’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $4.79M | Sell |
|
|||||
|
2022
Q1 | $4.74M | Buy |
|
|||||
|
2021
Q4 | $3.81M | Buy |
|
|||||
|
2021
Q3 | $3.14M | Buy |
|
|||||
|
2021
Q2 | $3.55M | Sell |
|
|||||
|
2021
Q1 | $6.86M | Buy |
|
|||||
|
2020
Q4 | $3.38M | Hold |
|
|||||
|
2020
Q3 | $3.38M | Sell |
|
|||||
|
2020
Q2 | $3.35M | Buy |
|
|||||
|
2020
Q1 | $3.09M | Sell |
|
|||||
|
2019
Q4 | $3.75M | Sell |
|
|||||
|
2019
Q3 | $2.97M | Buy |
|
|||||
|
2019
Q2 | $2.65M | Sell |
|
|||||
|
2019
Q1 | $2.86M | Sell |
|
|||||
|
2018
Q4 | $3.15M | Sell |
|
|||||
|
2018
Q3 | $3.86M | Sell |
|
|||||
|
2018
Q2 | $3.52M | Sell |
|
|||||
|
2018
Q1 | $4.08M | Buy |
|
|||||
|
2017
Q4 | $3.78M | Buy |
|
|||||
|
2017
Q3 | $3.89M | Sell |
|
|||||
|
2017
Q2 | $3.47M | Sell |
|
|||||
|
2017
Q1 | $3.44M | Sell |
|
|||||
|
2016
Q4 | $3.78M | Sell |
|
|||||
|
2016
Q3 | $3.95M | Buy |
|
|||||
|
2016
Q2 | $5.28M | Sell |
|
|||||
|
2016
Q1 | $5.26M | Sell |
|
|||||
|
2015
Q4 | $5.16M | Sell |
|
|||||
|
2015
Q3 | $4.49M | Sell |
|
|||||
|
2015
Q2 | $5.06M | Sell |
|
|||||
|
2015
Q1 | $4.93M | Buy |
|
|||||
|
2014
Q4 | $4.43M | Sell |
|
|||||
|
2014
Q3 | $3.98M | Sell |
|
|||||
|
2014
Q2 | $3.82M | Sell |
|
|||||
|
2014
Q1 | $4.57M | Sell |
|
|||||
|
2013
Q4 | $4.72M | Sell |
|
|||||
|
2013
Q3 | $4.23M | Sell |
|
|||||
|
2013
Q2 | $4.34M | Buy |
|